 Johnson  Johnson said it would begin testing an Ebolavirus vaccine in humans in January and could have  doses available in May if health authorities deem it safe and promising enough to distribute more broadly There is no approved vaccine guarding against the deadly Ebola virus The regimen under development by JJ in partnership with Denmarkbased biotechnology company Bavarian Nordic would be the latest in a race to get vaccines into human testinga crucial step in establishing whether an experimental
  